Sun, Yingying <br/><br/>
Mechanism Underlying the Effectiveness of Deferiprone in Alleviating Parkinson's Disease Symptoms.  [electronic resource] 

 -  ACS chemical neuroscience  05 2018 
 - 1118-1127 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1948-7193 
<br/><br/><label>Standard No.: </label>10.1021/acschemneuro.7b00478  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Deferiprone--pharmacology<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Iron--metabolism<br/>Iron Chelating Agents--pharmacology<br/>Oxidative Stress--drug effects<br/>Parkinson Disease--drug therapy<br/>Parkinson Disease, Secondary--drug therapy